Back to search

Netherlands· NL-6cc76404ea15

Alfacalcidol Theramex 1 microgram, capsules

A alfacalcidol product containing alfacalcidol, registered in Netherlands by Theramex Ireland Limited. The same ATC class is registered in 16 of our 19 countries.

ATC A11CC03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAlfacalcidol Theramex 1 microgram, ca…ATCA11CC03REGISTER NO.NL-6cc76404ea15PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Alfacalcidol is registered in 16 of 19 countries.

Countries holding a registration under ATC A11CC03 (alfacalcidol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose

Alfacalcidol · ATC A11CC03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of alfacalcidol costs, country by country.

Normalised to the WHO defined daily dose (1 mcg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Alfacalcidol · price per daily dose (1 mcg)

USD · FX 28 Sept 2026

  • IT Italy$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ALFACALCIDOL
Manufacturer
Theramex Ireland Limited
Country
Netherlands (NL)
ATC code
A11CC03
ATC class
Alfacalcidol
Defined daily dose
1 mcg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    10891

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Alfacalcidol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All alfacalcidol products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Etalpha
  • Belgium · Etalpha
  • Bulgaria · Алфа Д3
  • Cyprus · Emarfen, One-Alpha
  • Czechia · Alfacalcidol Cande, Alpha D3
  • Germany · Alfacalcidol Al, Alfacalcidol Aristo
  • Denmark · Alfacalcidol Strides, Etalpha
  • Estonia · Alfacalcidol Strides Pharma
  • Spain · Etalpha
  • Finland · Alfacalcidol Strides, Etalpha
  • France · Alfacalcidol Crinex, Alfacalcidol Theramex
  • United Kingdom (Northern Ireland) · Alfacalcidol, Alfacalcidol Crescent Pharma
  • Greece · A-Ostin-D3, Alestopor
  • Hungary · Alpha D3
  • Ireland · One-Alpha
  • Iceland · Etalpha
  • Italy · Alfacalcidolo Doc, Alfacalcidolo Zentiva
  • Lithuania · Alfacalcidol Strides Pharma
  • Luxembourg · Etalpha
  • Latvia · Alfacalcidol Strides
  • Malta · One-Alpha, V-D-Bone
  • Norway · Alfacalcidol Strides, Etalpha
  • Poland · Alfadiol
  • Portugal · Etalpha
  • Romania · Alfacalcidol Gemax Pharma, Alfacalcidol Heaton
  • Sweden · Alfacalcidol Pharma Scientific, Etalpha
  • Slovenia · Alpha D3
  • Slovakia · Alfacalcidol Medreg, Alfacalcidol Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d1c7adc5-4f4a-45cd-abbd-a746a469a140
GET /v1/drugs/d1c7adc5-4f4a-45cd-abbd-a746a469a140?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, zacht",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h10891_smpc.pdf",
  "strength": null,
  "atc_label": "Alfacalcidol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg10891",
  "excipients": [
    "ARACHIDEOLIE",
    "CITROENZUUR 0-WATER (E 330)",
    "ETHANOL",
    "GELATINE (E 441)",
    "GLYCEROL 85 PER CENT (E 422)",
    "IJZEROXIDE GEEL (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MANNITOL (D-) (E 421)",
    "PROPYLGALLAAT (E 310)",
    "SCHELLAK (E 904)",
    "SORBITAN",
    "SORBITOL (E 420)",
    "TITAANDIOXIDE (E 171)",
    "TOCOFEROL, DL-ALFA (E 307)",
    "ZWARTE INKT"
  ],
  "substances": [
    "ALFACALCIDOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h10891.pdf",
  "authorised_at": "1985/06/04",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "10891",
  "additional_monitoring": "N"
}

See everything about alfacalcidol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.